Biologic preserving composition and methods of use
AssigneeAesthetics Biomedical, Inc.
InventorShaun Wootten
Life of this patent
Estimating the term…
Abstract
Disclosed herein are compositions, methods, and systems for treating skin damage or signs of aging in a subject including obtaining whole blood from the subject, collecting platelet rich plasma (PRP) from the whole blood, forming a first topical formulation having the PRP, providing the first topical formulation to the subject for application to an area of skin damage on the subject, providing a second topical formulation to the subject having an activator such that when the second topical formulation is applied to the area of skin damage on top of the first formulation, the PRP is activated and growth factors are released into the area of skin damage. Systems and kits useful in performing the methods are also disclosed.
Claims55
A base composition for prolonging, preserving, or maintaining a biologic, the composition comprising:
- a cell nutrient;
- a biological buffer;
- polyacrylate crosspolymer-6;
- a thymol;
- and
- an anti-microbial.
A topical formulation, comprising:
- a base composition comprising a cell nutrient, a biological buffer, a viscosity modifying agent, a thymol, and an anti-microbial;
- and
- a biologic,
- wherein the formulation is formulated as a cream, lotion, salve, paste, serum, gel, ointment, liquid, solution, spray, aerosol, or foam.
A method of diminishing pore size, diminishing bacteria damage, diminishing red areas, reducing skin damage caused by sun, and maintaining or improving skin tone in a subject in need thereof, the method comprising:
- obtaining whole blood from a subject having an area of skin damage or a skin disorder;
- centrifuging the blood to separate platelet rich plasma from platelet poor plasma and red blood cells;
- collecting the platelet rich plasma (PRP);
- adding a base composition comprising a cell nutrient, a biological buffer, a viscosity modifying agent, a thymol, and an anti-microbial to the PRP to form PRP admixed solution thereby forming a first topical formulation, wherein the base composition maintains activity of the PRP for a period of time ranging from 30 to 120 days;
- and
- providing the first topical formulation for application to the subject for treatment of the area of skin damage.
Dependencies are inferred from the claim text.